Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

What Markman should mean to you

The Supreme Court's decision on Markman will impact your biotechnology company if there is an infringement trial.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. McGill Inc. v. John Zink Co., 746 F.2d 666, (Fed. Cir. 1984).

  2. 35 U.S.C. §112, ¶1

  3. US Patent ♯ 4965204 at issue in Johns Hopkins University v Cellpro 894 F.Supp.819.

  4. 35 U.S.C.§112, ¶2

  5. Read Corp v. Portec, Inc., 970 F.2d 816, 821, 23 U.S.P.Q.2d 1426,1431 (Fed.Cir. 1992).

  6. Id.

  7. See Arnold, A Historical Inquiry into the Right to Trial by Jury in Complex Civil Litigation, 28 U. Pa. L. Rev. 829 (1980); see also SRI International v. Matsushita Electric Corp. of America, 775 F.2d 1107, 227 U.S.P.Q. 577 (Fed. Cir. 1985).

    Article  Google Scholar 

  8. Markman v. Westview Instr., Inc., 52 F.3d 967, (Fed.Cir. 1995) (en banc).

  9. Id at 979.

  10. Id.

  11. Exxon Chemical Patent, Inc., v. Lubrizol Corporation, 64 F.3d 1553, 35 U.S.P.Q.2d 1801 (Fed.Cir. Sept. 1, 1995).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rzucidlo, E., Auth, D. What Markman should mean to you. Nat Biotechnol 14, 888–890 (1996). https://doi.org/10.1038/nbt0796-888

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0796-888

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing